Satellos Bioscience Inc. (MSLE) Operating cash flow 2024–2025
Satellos Bioscience Inc. (MSLE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.6MFY2025 · since FY2024: -$18.3M → -$23.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.6M | -29.3% |
| FY2024 | -$18.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MSLE financial trends
MSLE RevenueMSLE Net incomeMSLE Net marginMSLE Gross profitMSLE Gross marginMSLE Operating incomeMSLE Operating marginMSLE Free cash flowMSLE Capital expendituresMSLE Return on equityMSLE Stock buybacksMSLE Dividends paidMSLE Total assetsMSLE Total liabilitiesMSLE Shareholders’ equityMSLE overview →